[Peripheral nerve damage and its pathogenesis induced by antiepileptic drugs in rats]

Min Zhong1, Fang-cheng Cai, Xiao-ping Zhang

  • 1Department of Neurology, Children's Hospital of Chongqing Medical University, China.

Insights

Certain antiepileptic drugs (AEDs) can cause peripheral nerve damage, primarily demyelination, in both adult and infant rats. While susceptibility is similar, younger rats show better recovery, and oxidative stress plays a key role.

Area of Science:

  • Neuroscience
  • Pharmacology
  • Toxicology

Context:

  • Antiepileptic drugs (AEDs) are crucial for managing epilepsy but may have off-target effects.
  • Peripheral nerve damage (neuropathy) is a potential adverse effect of some medications.
  • Understanding age-related susceptibility and pathogenesis is vital for drug safety.

Purpose:

  • To investigate the potential of seven AEDs to induce peripheral nerve damage in adult and infant rats.
  • To explore the underlying pathogenetic mechanisms, including oxidative stress and apoptosis.
  • To compare the susceptibility and recovery patterns between different age groups.

Summary:

  • Six AEDs (phenytoin, phenobarbital, sodium valproate, clonazepam, carbamazepine, oxcarbazepine) induced peripheral nerve damage, predominantly demyelination, in both adult and infant rats.
  • Susceptibility was similar across age groups, but infant rats exhibited better recovery of nerve damage after drug withdrawal.
  • Oxidative stress, indicated by reduced antioxidant capacity, was closely linked to nerve damage, while spinal cord neuron apoptosis did not correlate significantly.

Impact:

  • Identifies specific AEDs with a risk of peripheral neuropathy, informing clinical practice.
  • Highlights the role of oxidative stress in AED-induced nerve damage.
  • Provides insights into age-dependent differences in drug-induced neurotoxicity and recovery.
Abstract

Related Concept Videos

Antiepileptic Drugs: GABAergic Pathway Potentiators01:18

Antiepileptic Drugs: GABAergic Pathway Potentiators

γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for their...
Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Antiepileptic Drugs: Glutamate Antagonists01:14

Antiepileptic Drugs: Glutamate Antagonists

Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
Antiepileptic Drugs: Potassium Channel Activators01:20

Antiepileptic Drugs: Potassium Channel Activators

Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Secondary Spinal Cord Injury llI: Pathophysiology01:25

Secondary Spinal Cord Injury llI: Pathophysiology

Early Ischemia and Ionic ImbalanceWithin minutes of spinal cord injury, a secondary cascade begins, progressing over hours to weeks. Vascular damage reduces blood flow, causing ischemia and mitochondrial dysfunction. ATP depletion leads to ion pump failure, membrane depolarization, sodium influx, potassium efflux, and water accumulation, resulting in cellular swelling. Increased intracellular calcium further disrupts mitochondria and accelerates cellular injury.Excitotoxicity and Neuronal...
Antiepileptic Drugs: Sodium Channel Blockers01:08

Antiepileptic Drugs: Sodium Channel Blockers

Antiepileptic drugs are specialized medications that prevent seizures in individuals diagnosed with epilepsy. These drugs primarily function by blocking the movement of sodium ions through channels in the neuronal membrane, inhibiting the repetitive firing of action potentials often associated with seizures.
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...